Mark W. Nowak Email and Phone Number
Mark W. Nowak work email
- Valid
- Valid
- Valid
Mark W. Nowak personal email
- Valid
We have developed an easy-to-use Dynamic Clamp System, the Cybercyte, that allows for the integration of electronically-generated ion channel currents in real time (50 kHz sampling rate) into signals recorded from cultured cardiomyocytes and neurons. Our system uses both Markov and Hodgkin-Huxley models. Importantly, our dynamic clamp system easily incorporates into your existing electrophysiology amplifier system.Applications/Features of our Dynamic Clamp System:1) Restore the physiological resting membrane potential of stem cell-derived cardiomyocytes by the electronic addition of IK1 to stem cell-derived cardiomyocytes (hiPSC-CM) enabling detailed quantitative analysis of action potentials (APs).2) Real-time passive leak correction improving the accuracy and efficiency of electrophysiological recording of hiPSC-CM APs. 3) Neuronal Dynamic Clamp System:a. Library of neuronal ion channel current models.b. Library of rectifying background K+ currents for establishing physiological resting membrane potentials and recording of stable APs in hiPSC neurons.c. Input a recorded current trace as a conductance (with variable magnitude and reversal potential control)d. Input a real-time optical signal (e.g., Ca++ sensitive dye fluorescence) to drive electronic expression of an ion channel (e.g., Ca++-dependent K+ current)4) Synthetic Cell Modea. Ability to input a real current expressed in a cell into an in silico model of a cardiomyocyte or neuron b. Coupling NEURON simulation software with our dynamic clamp system allowing for input of a real current expressed in a cell into in silico NEURON models5) GUI-based Markov Model solver software (included with dynamic clamp system) which allows the user to easily test their own models or published models. A channel definition file can be generated and easily uploaded into our dynamic clamp software.We also offer custom electrophysiology services and are capable of recording ion channel currents in a variety of cell lines (e.g., HEK), hiPSCDs and primary cells (cardiomyocytes, neurons). We also are capable of recording cardiac and neuronal action potentials. Finally, we offer custom ion channel modeling services.In addition to our dynamic clamp system, we offer far red voltage-sensitive dyes (Cytovolt1 and Cytovolt2) for recording APs using fluorescence as well as a sensitive fluorescence detection system.
Cytocybernetics (Www.Cytocybernetics.Com)
View-
Lead ScientistCytocybernetics (Www.Cytocybernetics.Com) Dec 2015 - PresentBuffalo, New York, UsWe have developed a user friendly plug and play Dynamic Clamp system, the Cybercyte, that allows for the integration of electronically-generated ion channel currents in real time into signals recorded from cardiomyocytes, neurons and common cell lines. We use both Markov models and Hodgkin-Huxley models, as needed. We can electronically express a wide range of currents, including INa, ICa, IKS, IK1 and IHERG. One of our applications is to use the Cybercyte to record stable cardiac action potentials from Induced pluripotent adult stem cell-derived cardiac myocytes (iPSCD_CM). iPSCD-CMs are limited in studying integrated cardiac action potentials since they lack the IK1 potassium channel. The Cybercyte electronically expresses IK1, which restores the physiological diastolic potential enabling detailed quantitative analysis of iPSCD_CM action potentials. We further improved the accuracy and efficiency of recording cardiac action potentials using the Cybercyte to correct in real-time increases in passive leak that routinely occur in patch clamp electrophysiology recording. Using the Cybercyte we provide early-stage cardiotoxicity screening of lead candidates for the pharmaceutical industry in accordance with the FDA's Comprehensive In Vitro Proarrhythmia Assay (CiPA) initiative. -
Pre-Clinical Drug DevelopmentEncode Bio, Inc. Jan 2006 - Mar 2015- Directed a research program dedicated to the development of therapeutic, bioactive peptides targeting inflammatory diseases.- Led all vision, strategy, and execution for drug development initiatives.- Developed the unique ability to balance scientific advances with business considerations from cost, feasibility, market advantage, and end user perspective.KEY ACHIEVEMENTS- Successfully secured grants from the National Institutes of Health, one of the world's foremost medical research centers, totaling $1.4MM.- Key developments and accomplishments include cell-based assays for drug screening, as well as an in vivo orally-available peptide drug with potent (μg/kg) efficacy in mouse inflammatory models, presently under patent consideration by the USPTO.- Designed and advanced studies testing the peptide in inflammatory mouse models, as well as pre-clinical studies assessing pharmacokinetic/pharmacodynamic properties and safety to support an FDA Investigational New Drug (IND) application.- Contributed additional leadership expertise managing a research program to develop drug screening assays that identify inhibitors of protein-protein interactions by incorporation of reactive amino acids using unnatural amino acid mutagenesis. -
Molecular NeuroscienceNeurion Pharmaceuticals, Inc. Jan 2003 - Jan 2006Us- Effectively managed all molecular neuroscience functions at this ion channel drug discovery company, focusing on identifying drug-ion channel interactions and the discovery of small molecule drug therapies for diseases and disorders of the central nervous system.- Formed strategic partnerships with industry leading pharmaceutical companies, including Pfizer, Eli Lilly, Amgen, and Merck, to select and validate drug candidates for interaction with ion channels using unnatural amino acid mutagenesis/electrophysiology-based assays.KEY ACHIEVEMENTS- Secured $800K in grants from the NIH, while developing innovative and effective strategies to design experiments and achieve results using limited resources.- Leveraged superior subject matter expertise to train and mentor molecular biology and electrophysiology personnel.- Collected and compiled all research findings into reports for submittal to internal stakeholders and pharmaceutical partners. -
Assistant Professor, Department Of PsychiatryMedical University Of South Carolina Jul 1997 - Jan 2003Charleston, Sc, Us- Managed a laboratory dedicated to the study of the effects of ethanol and nicotine on neurotransmission/ion channel function at this private college for the training of physicians- Facilitated the progress of multiple concurrent research projects in this and other areas, including animal research via collaborations with basic and clinical researchers.KEY ACHIEVEMENTS- Collaborated with colleagues and supervised MD-PhD and PhD students in The Center for Drug and Alcohol Programs, one of the nation’s premier academic centers for the study and treatment of alcohol and substance abuse; examined the molecular expression pattern of GABAAR in mouse models of ethanol-induced seizures.- Recipient of a highly competitive NIAAA KO1 grant from the NIH as well as a MUSC University Research Council Grant. -
Senior Research FellowCalifornia Institute Of Technology Feb 1992 - May 1997Pasadena, Ca, Us- Assumed a lead role directing the efforts of a multi-disciplinary research team engaged in the study of neurotransmission/ion channels using unnatural amino acid mutagenesis.KEY ACHIEVEMENTS- Secured greater insights into the molecular determinants underlying agonist interactions with ligand-gated ion channels.- Recipient of two highly competitive fellowships, the American Heart Association Fellowship and the NIH Post-doctoral Fellowship.
Mark W. Nowak Skills
Mark W. Nowak Education Details
-
University At BuffaloPharmacology -
Case Western Reserve UniversityBiochemistry
Frequently Asked Questions about Mark W. Nowak
What company does Mark W. Nowak work for?
Mark W. Nowak works for Cytocybernetics (Www.cytocybernetics.com)
What is Mark W. Nowak's role at the current company?
Mark W. Nowak's current role is Cytocybernetics (real-time, plug-n-play Dynamic Clamp system, pro-arrhythmic drug screening, electrophysiogical recording services, high-sensitivity photodetector system, voltage-sensitive dyes,).
What is Mark W. Nowak's email address?
Mark W. Nowak's email address is mw****@****hoo.com
What schools did Mark W. Nowak attend?
Mark W. Nowak attended University At Buffalo, Case Western Reserve University.
What skills is Mark W. Nowak known for?
Mark W. Nowak has skills like Drug Discovery, Molecular Biology, Biochemistry, Drug Development, Assay Development, Pharmacology, Electrophysiology, Life Sciences, Biotechnology, Western Blotting, Tissue Culture, Protein Chemistry.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial